bromsite
(bromfenac)Sun Pharmaceutical Industries, Inc.
Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.
5 results
dexycu
(dexamethasone)EyePoint Pharmaceuticals US, IncUsage: DEXYCU (dexamethasone intraocular suspension) 9% is indicated for the treatment of postoperative inflammation following eye surgery.ketorolac tromethamine
(ketorolac tromethamine)SOLA Pharmaceuticals, LLCUsage: Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching caused by seasonal allergic conjunctivitis and for treating postoperative inflammation in patients who have undergone cataract extraction.ketorolac tromethamine
(ketorolac tromethamine)Sandoz IncUsage: Ketorolac tromethamine ophthalmic solution is indicated for temporary relief of ocular itching from seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.prolensa
(Bromfenac Sodium)Bausch & Lomb IncorporatedUsage: PROLENSA® (bromfenac ophthalmic solution) 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.